Weanling pigs in groups of 12 were infected orally with Salmonella choleraesuis and were treated intramuscularly with doses of cephamycin C ranging from 12.5 to 337.5 mg twice daily for 10 days beginning 1 day postinoculation. Pigs in two other infected groups either received 300 mg of tetracycline orally on a similar schedule or served as nonmedicated controls. Optimal responses to cephamycin C were achieved at a twice daily dose of 112.5 mg. With this regimen, the febrile response was significantly reduced on day 2 and eliminated by day 5 postinfection, and the shedding of Salmonella spp. in feces was eliminated by day 7 postinfection; essentially, no lesions were found in the gastrointestinal tract at necropsy (day 26 postinfection). There was no mortality among recipients of the 112.5-mg dose; diarrhea was present on only 2% of the observation days. In contrast, 83% of the infected, nonmedicated pigs and 25% of the tetracycline-medicated pigs died, and diarrhea was present in these groups on 63 and 54% of the observation days, respectively. The striking benefits of cephamycin C treatment were achieved without adverse reactions. The weight gain and feed efficiency of the infected pigs treated with the 112.5-mg dose of cephamycin C and the noninfected, nonmedicated control pigs were equivalent.
Weanling pigs in groups of 12 were infected orally with Salmonella choleraesuis and were treated intramuscularly with doses of cephamycin C ranging from 12.5 to 337.5 mg twice daily for 10 days beginning 1 day postinoculation. Pigs in two other infected groups either received 300 mg of tetracycline orally on a similar schedule or served as nonmedicated controls. Optimal responses to cephamycin C were achieved at a twice daily dose of 112.5 mg. With this regimen, the febrile response was significantly reduced on day 2 and eliminated by day 5 postinfection, and the shedding of Salmonella spp. in feces was eliminated by day 7 postinfection; essentially, no lesions were found in the gastrointestinal tract at necropsy (day 26 postinfection). There was no mortality among recipients of the 112.5-mg dose; diarrhea was present on only 2% of the observation days. In contrast, 83% of the infected, nonmedicated pigs and 25% of the tetracycline-medicated pigs died, and diarrhea was present in these groups on 63 and 54% of the observation days, respectively. The striking benefits of cephamycin C treatment were achieved without adverse reactions. The weight gain and feed efficiency of the infected pigs treated with the 112.5-mg dose of cephamycin C and the noninfected, nonmedicated control pigs were equivalent.
Cephamycin C, a 18-lactam antibiotic produced by Streptomyces lactamdurans, has a broad spectrum of activity against gram-negative organisms in vitro (7) and in vivo (8) and is resistant to degradation by /8-lactamases (3). It has recently been shown to be highly effective in treating induced enterotoxigenic colibacillosis (scours) in both calves and piglets (6) . This report is concerned with the activity of cephamycin C against an experimentally induced Salmonella cholerae-suis infection in weanling swine. Salmonella spp. isolations. Two rectal swabs from each pig were examined for Salmonella spp. before inoculation with S. cholerae-suis. Rectal swabs from each pig were examined for Salmonella spp. on days 7, 14, and 21 PI. At necropsy four tissue samples from each pig, including ileocecal lymph node, liver, spleen, and colon swab, were examined for Salmonella spp. Feed, fecal, or tissue samples were streaked directly onto xylose lysine, brilliant green agar and incubated for 24 h. at 370C. Colonies suspected of being Salmonella spp. were picked and inoculated into triple sugar iron agar and lysine iron agar tubes and incubated at 370C for 24 h. Serological typing was then used to determine the SalmoneUa serogroup.
MATERIALS AND METHODS
Numbers ofinoculated S. cholerae-suis in feces at day 2 postinoculation. Freshly collected fecal samples (1 g each) were homogenized in 9 ml of 0.01 M phosphate-buffered saline (pH 7.2) and diluted serially in this fluid; 0.1-ml quantities of 10-2, 10-4, and 10-' dilutions were plated in duplicate on xylose lysine, brilliant green agar. The numbers of colonies of S. cholerae-suis on these plates were determined after a 24-h incubation at 370C. Where available, five clones from each fecal sample suspected of being Salmonella spp. were picked from the xylose lysine, brilliant green agar plates and inoculated into triple sugar iron agar and lysine iron agar tubes and incubated at 370C for 24 h. Serological typing was then used to assure the isolates were Salmonella serogroup C.
Lesions at necropsy. All pigs, when they died or were killed at the end of the experiment, were examined for macroscopic lesions typical of salmonellosis. Pigs dead at 8:00 a.m. were sufficently well preserved to allow examination for macroscopic lesions. The lesions were scored as follows: 0, no lesions present; 1, mild inflammatory changes in the colon or cecum or both, colitis with no evidence of necrosis, feces usually soft or loose, cecal or colonic walls or both slightly thickened; 2, cecal and colonic walls thickened, edematous and with ecchymotic hemorrhages or focal caseous necrosis or both, feces generally loose or watery, mesenteric lymph nodes with peripheral hyperemia and enlargement, splenomegaly sometimes present; 3, cecal and colonic walls thickened, edematous and with extensive hemorrhages or caseous necrosis or both, feces loose or watery, mesenteric lymph nodes with peripheral hyperemia and enlargement, splenomegaly sometimes present.
Statistical methods. Analysis of variance for a completely randomized design and Duncan's New Multiple Range Test (13) for pairwise comparisons of means were used. All pairwise comparisons of means of treatment groups were examined, and in the tables any two means that do not have a lettered superscript in common are statistically significantly different at the P < 0.05 level. The experimental units were the individual swine, unless otherwise indicated that the group of swine in the pen was used as the unit. On all percentage data in which the group of swine in the pen was used as the experimental unit, a double arcsine transformation was used and is defined as follows:
arcsine rI/n + 1 + arcsine J(r + 1)/(n + 1), where r = number in pen affected and n = total number in pen.
RESULTS
Noninoculated (noninfected) pigs were asymptomatic throughout the experiment, except for sporadic diarrhea (on days 1 through 13 of the experiment, 6 of the 12 pigs had diarrhea for 1, 2, or 3 days).
Initial clinical signs of salmonellosis in infected pigs consiAted of a febrile response, anorexia, some vomiting, and loose or watery stools which appeared from 1 to 4 days PI. Diarrhea continued in some pigs up to the end of the experiment (day 26 PI). Deaths occurred between days 4 h Analyzed by using the group of swine in the pen as the unit. c Percent diarrhea = 100% x total number postinoculation diarrhea days/total number postinoculation days observed. S, Surviving pigs (pigs that were alive on day 26 PI); D, dead pigs (pigs that died before day 26 PI). In the nonmedicated group, deaths occurred between days 5 and 11 PI; in the medicated groups deaths occurred between days 4 and 19 PI.
d Feed efficiency = weight gain/feed consumed. Analyzed by using the group of swine in the pen as the unit, with both surviving and dead pigs included. 37.5 mg b.i.d., cephamycin C significantly reduced both diarrhea and mortality and was comparable to tetracycline at 300 mg b.i.d. orally. The 12.5-mg b.i.d. level of cephamycin C was not effective in treating this salmonellosis.
The weight gains and feed efficiencies of the pigs treated with cephamycin C at 337.5 and 112.5 mg b.i.d. and the noninfected, nonmedicated control pigs were equivalent ( Table 3) . The pigs treated with these two highest levels of cephamycin C had essentially no gut lesions at necropsy.
All fecal samples from the pigs before inoculation and from the noninfected, nonmedicated control pigs throughout the study were negative for Salmonella spp. In the counts at 2 days PI, S. cholerae-suis was detected at a concentration -1,000 colony-forming units per g of feces in some pigs in all infected groups (Table 4) . The groups treated with cephamycin C at 337.5 and 112.5 mg b.i.d. had significantly fewer pigs with counts -1,000 colony-forming units per g of feces, and none of the pigs in these groups were shedding S. cholera-suis in their feces from day 7 PI to the end of the experiment (day 26 PI).
At necropsy S. cholerae-suis was isolated from the tissues of 11 of 12 (89 to 95%) infected, nonmedicated pigs (Table 5 ). The groups medicated with cephamycin C at 337. 5 b Tetracycline administered orally, cephamycin C administered intramuscularly.
c Analyzed by using the group of swine in the pen as the unit. CFU, Colony-forming units. of the disease resembled those found in natural outbreaks and those described for experimentally induced S. cholerae-suis disease (4, 5, 9, 12) . The initial clinical signs were pyrexia with anorexia and some vomiting, then diarrhea, and eventually death in nomnedicated pigs. On necropsy the most apparent gross lesions were found in the large intestine, where the walls of the cecum and colon were thickened and the mucous membrane was necrotic. The challenge S. cholerae-suis was routinely recovered at necropsy from the tissues of nonmedicated pigs.
Most of the antibiotics, nitrofurans, and sulfonamides used in animal health have been reported to be effective alone or in combination in prevention or treatment or both of swine salmonellosis under field or experimental conditions (2, 9-11). To rank these antibacterial agents for efficacy is difficult because of the varying severity of the disease conditions under which they were evaluated. In one study (11) , wherein severity of disease was comparable to that in our study, infected, nonmedicated pigs had 80% mortality, whereas pigs medicated with nitrofurazone in water had 40% mortality, pigs medicated with furazolidone in feed had 60% mortality, and pigs medicated with chlortetracycline, sulfamethazine, plus penicillin in feed had 50% mortality. Furthermore, the average daily weight gain of each medicated group of pigs was approximately one half that of the noninfected, nonmedicated group. Comparison of the results reported for this study (11) with the observations made in our study is instructive. Cephamycin C prevented mortality and maintained the weight gain of infected, medicated pigs so that it was equivalent to the weight gain of the noninfected, nonmedicated control pigs. Such advantage shows that cephamycin C is a highly effective treatment for swine salmonellosis. Recent studies have shown cephamycin C to be highly effective in treating inducing enterotoxigenic colibacillosis (scours) in both calves and piglets (6) . In addition, in vitro studies (unpublished data) with multiply resistant enteropathogenic Escherichia coli and Salmonella spp. have shown no resistance to this drug.
These facts, combined with its resistance to degradation by 8i-lactamases, make cephamycin C a potentially useful drug for treatment of salmonellosis and colibacillosis in livestock industries.
